Selenium nanoparticles enhance the anti-tumor immune responses of anti-4-1BB antibody and alleviate the adverse effects on mice von zhang, Lei, Liu, Houru, Shen, Jie, Liu, Wenting, Liu, Dahai, Cheng, Liansheng, Huang, Bei

Volltext

917 A novel B7H3×4–1BB bispecific antibody for solid tumor treatment von Cheng, Liansheng, Zhao, Qun, Zhang, Dayan

Volltext

1055 Heterodimeric Fc-fused IL12 shows potent antitumor activity and low toxicity von Liu, Wenting, Zhang, Dayan, Zhou, Pengfei, Shen, Guodong, Zeng, Xiaoli, Zhou, Weiming, Cheng, Liansheng

Volltext

1192 A novel MSLN×4–1BB bispecific antibody for solid tumor von Zhang, Dayan, Liu, Wenting, Shen, Guodong, Zhou, Weiming, Zeng, Xiaoli, Cheng, Liansheng

Volltext

In vivo activity of novel anti-ErbB2 antibody chA21 alone and with Paclitaxel or Trastuzumab in breast and ovarian cancer xenograft models von Shen, Guodong, Huang, Hui, Zhang, Anli, Zhao, Ting, Hu, Siyi, Cheng, Liansheng, Liu, Jing, Xiao, Weihua, Ling, Bin, Wu, Qiang, Song, Lihua, Wei, Wei

Volltext

Structural insight into HEMK2-TRMT112-mediated glutamine methylation von Gao, Jie, Wang, Bin, Yu, Huijuan, Wu, Gao, Wan, Cuihong, Liu, Wenting, Liao, Shanhui, Chen, Liansheng, Zhu, Zhongliang

Volltext

Construction of 89ZrZr-Labeled HuL13 for ImmunoPET Imaging of LAG-3 Checkpoint Expression on Tumor-Infiltrating T Cells von Ding, Lixin, Wang, Feng, Wang, Zilei, Pan, Yongxiang, Liu, Teli, Cheng, Liansheng, Liu, Wenting, Ding, Kuke, Zhu, Hua, Yang, Zhi

Volltext

Construction of [89Zr]Zr-Labeled HuL13 for ImmunoPET Imaging of LAG‑3 Checkpoint Expression on Tumor-Infiltrating T Cells von Ding, Lixin, Wang, Feng, Wang, Zilei, Pan, Yongxiang, Liu, Teli, Cheng, Liansheng, Liu, Wenting, Ding, Kuke, Zhu, Hua, Yang, Zhi

Volltext

Structure of the platelet glycoprotein Ib receptor in complex with a novel antithrombotic agent von Wang, Jing, Gao, Yongxiang, Chen, Lan, Guo, Yugang, Hu, Siyi, Cheng, Liansheng, Xiao, Weihua, Ke, Jiyuan, Zhu, Zhongliang, Niu, Liwen

Volltext

Structural insight into a matured humanized monoclonal antibody HuA21 against HER2‐overexpressing cancer cells von Wang, Zhenyi, Cheng, Liansheng, Guo, Gongrui, Cheng, Baoyun, Hu, Siyi, Zhang, Hongmin, Zhu, Zhongliang, Niu, Liwen

Volltext

Anti-HER-2 engineering antibody ChA21 inhibits growth and induces apoptosis of SK-OV-3 cells von Zhang, Anli, Xue, Hua, Ling, Xiaoguang, Gao, Yi, Yang, Feng, Cheng, Liansheng, Liu, Jing, Wu, Qiang

Volltext

Abstract LB508: The development of HK013, a bispecific antibody targeting MSLN and CD137, for the treatment of MSLN+ solid tumors von Xu, Xing, Zhang, Dayan, Liu, Wenting, Shen, Guodong, Cheng, Liansheng

Volltext

A NOVEL MSLN×4-1BB BISPECIFIC ANTIBODY FOR SOLID TUMOR von Cheng, Liansheng, Zhang, Dayan, Liu, Wenting, Zhou, Weiming, Zeng, Xiaoli, Zhao, Qun, Shen, Guodong

Volltext

Abstract LB509: ZG033, a novel CD137 agonist, induces superior anti-tumor activity without hepatotoxicity rely on Fc-mediated crosslinking von Li, Liangwei, Liu, Wenting, Shen, Guodong, Zhang, Dayan, Zheng, Xiaoli, Cheng, Liansheng

Volltext

Abstract 6336: Heterodimeric Fc-fused IL12 shows potent antitumor activity and low toxicity von Huang, Yang, Liu, Wenting, Zhang, Dayan, Zhou, Pengfei, Zhou, Weiming, Zeng, Xiaoli, Zhao, Qun, Li, Liangwei, Shen, Guodong, Cheng, Liansheng

Volltext

Abstract 5657: HK010, a novel anti-PDL1 × CD137 bispecific antibody, exhibits potent anti-tumor immunity and low toxicity von Li, Liangwei, Liu, Wenting, Shen, Guodong, Zhang, Dayan, Zhou, Weiming, Wang, Fengrong, Zeng, Xiaoli, Huang, Yang, Cheng, Liansheng

Volltext

Abstract 1880: A novel CD137 agonist exhibits potent antitumor efficacy with a good safety profile von Huang, Yang, Li, Liangwei, Liu, Wenting, Zhang, Dayan, Zhou, Pengfei, Fang, Qing, Zhou, Weiming, Wang, Fengrong, Shen, Guodong, Cheng, Liansheng

Volltext

Abstract 6338: Development of a novel MSLN × 4-1BB bispecific antibody von Li, Liangwei, Zhang, Dayan, Shen, Guodong, Liu, Wenting, Zeng, Xiaoli, Wu, Lingling, Zhao, Qun, Zhou, Weiming, Huang, Yang, Cheng, Liansheng

Volltext

A novel 4-1BB/HER2 bispecific antibody shows potent antitumor activities by increasing and activating tumor-infiltrating T cells von Shen, Aolin, Liu, Wenting, Wang, Huizhen, Zeng, Xiaoli, Wang, Mengli, Zhang, Dayan, Zhao, Qun, Fang, Qing, Wang, Fengrong, Cheng, Liansheng, Shen, Guodong, Li, Yongxiang

Volltext

Structural insights into the down-regulation of overexpressed p185(her2/neu) protein of transformed cells by the antibody chA21 von Zhou, Huihao, Zha, Zhao, Liu, Yang, Zhang, Hongtao, Zhu, Juanjuan, Hu, Siyi, Shen, Guodong, Cheng, Liansheng, Niu, Liwen, Greene, Mark I, Teng, Maikun, Liu, Jing

Volltext